Clinical trial
Effect of Early Oral Colostrum Administration Versus Placebo on the Immune System in Premature Newborns Under 32 Weeks of Gestation: A Randomized Clinical Trial.
NCT03578341 is registered in ClinicalTrials.gov with Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Early Oral Colostrum Administration Versus Placebo on the Immune System in Premature Newborns Under 32 Weeks of Gestation: A Randomized Clinical Trial.
- Lead sponsor
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- December 31, 2019
- Enrollment
- 96 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
immune system diseases, immunoglobulin deficiency, premature infant disease